18-78992542-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_171999.4(SALL3):​c.551G>A​(p.Gly184Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000027 in 1,482,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000067 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000023 ( 0 hom. )

Consequence

SALL3
NM_171999.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.795
Variant links:
Genes affected
SALL3 (HGNC:10527): (spalt like transcription factor 3) This gene encodes a sal-like C2H2-type zinc-finger protein, and belongs to a family of evolutionarily conserved genes found in species as diverse as Drosophila, C. elegans, and vertebrates. Mutations in some of these genes are associated with congenital disorders in human, suggesting their importance in embryonic development. This protein binds to DNA methyltransferase 3 alpha (DNMT3A), and reduces DNMT3A-mediated CpG island methylation. It is suggested that silencing of this gene, resulting in acceleration of DNA methylation, may have a role in oncogenesis. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.047964245).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SALL3NM_171999.4 linkuse as main transcriptc.551G>A p.Gly184Asp missense_variant 2/3 ENST00000537592.7 NP_741996.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SALL3ENST00000537592.7 linkuse as main transcriptc.551G>A p.Gly184Asp missense_variant 2/35 NM_171999.4 ENSP00000441823 P1Q9BXA9-1
SALL3ENST00000575389.6 linkuse as main transcriptc.551G>A p.Gly184Asp missense_variant 2/45 ENSP00000458360 Q9BXA9-2
SALL3ENST00000536229.7 linkuse as main transcriptc.152G>A p.Gly51Asp missense_variant 1/33 ENSP00000439975 Q9BXA9-3

Frequencies

GnomAD3 genomes
AF:
0.00000670
AC:
1
AN:
149178
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000665
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000268
AC:
3
AN:
111880
Hom.:
0
AF XY:
0.0000315
AC XY:
2
AN XY:
63410
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000143
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000225
AC:
3
AN:
1333092
Hom.:
0
Cov.:
30
AF XY:
0.00000303
AC XY:
2
AN XY:
659010
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000944
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000670
AC:
1
AN:
149178
Hom.:
0
Cov.:
33
AF XY:
0.0000138
AC XY:
1
AN XY:
72690
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000665
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 27, 2022The c.551G>A (p.G184D) alteration is located in exon 2 (coding exon 2) of the SALL3 gene. This alteration results from a G to A substitution at nucleotide position 551, causing the glycine (G) at amino acid position 184 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
11
DANN
Benign
0.89
DEOGEN2
Benign
0.028
.;T;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.099
N
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Benign
0.0082
T
MetaRNN
Benign
0.048
T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.0
L;L;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
0.56
.;N;.
REVEL
Benign
0.0030
Sift
Benign
0.78
.;T;.
Sift4G
Benign
0.76
T;T;T
Polyphen
0.18
.;B;.
Vest4
0.19
MutPred
0.34
Loss of MoRF binding (P = 0.0427);Loss of MoRF binding (P = 0.0427);.;
MVP
0.24
MPC
0.52
ClinPred
0.040
T
GERP RS
-2.6
Varity_R
0.033
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1308853356; hg19: chr18-76752542; API